Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw – work in progress and challenges

References

• MarxREPamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaws: a growing epidemicJ Oral Maxillofac Surg20036191115111712966493
   PubMed Web of Science ®Google Scholar
• RuggieroSLMehrotraBRosenbergTJEngroffSLOsteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJ Oral Maxillofac Surg200462552753415122554
   PubMed Web of Science ®Google Scholar
• MiglioratiCAWooSBHewsonIA systematic review of bisphosphonate osteonecrosis (BON) in cancerSupport Care Cancer20101881099110620411279
   PubMed Web of Science ®Google Scholar
• SmithMRSaadFColemanRDenosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trialLancet20123799810394622093187
   PubMed Web of Science ®Google Scholar
• KrugerTBSharikabadMNHerlofsonBBBisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reportingActa Odontol Scand20137161386139023351164
   PubMed Web of Science ®Google Scholar
• BergdahlJJarnbringFEhrensteinVEvaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish national patient registerClin Epidemiol201351723323023
   PubMedGoogle Scholar
• GammelagerHErichsenRAntonsenSPositive predictive value of the International Classification of Diseases, 10th revision, codes to identify osteonecrosis of the jaw in patients with cancerCancer Epidemiol201236438138322534488
   PubMed Web of Science ®Google Scholar
• GammelagerHSvaerkeCNoerholtSEValidity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish national registry of patientsClin Epidemiol2013526326723946670
   PubMedGoogle Scholar
• LoJCO’RyanFSGordonNPPrevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposureJ Oral Maxillofac Surg201068224325319772941
   PubMed Web of Science ®Google Scholar
• SolomonDHMercerEWooSBAvornJSchneeweissSTreisterNDefining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challengesOsteoporos Int201324123724422707065
   PubMed Web of Science ®Google Scholar
• KhoslaSBurrDCauleyJBisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral researchJ Bone Miner Res200722101479149117663640
   PubMed Web of Science ®Google Scholar
• FehmTBeckVBanysMBisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignanciesGynecol Oncol2009112360560919136147
   PubMed Web of Science ®Google Scholar
• AllenMRBurrDBThe pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few dataJ Oral Maxillofac Surg2009675 suppl617019371816
   PubMed Web of Science ®Google Scholar
• SaadFBrownJEVan PoznakCIncidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesAnn Oncol20122351341134721986094
   PubMed Web of Science ®Google Scholar
• Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the JawsAAOMSAmerican association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jawsJ Oral Maxillofac Surg200765336937617307580
   PubMed Web of Science ®Google Scholar
• RuggieroSLDodsonTBAssaelLALandesbergRMarxREMehrotraBAmerican association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaw – 2009 updateAust Endod J200935311913019961450
   PubMed Web of Science ®Google Scholar
• FedeleSPorterSRD’AiutoFNonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case seriesAm J Med2010123111060106420851366
   PubMed Web of Science ®Google Scholar
• BaganJVHens-AumenteELeopoldo-RodadoMPoveda-RodaRBaganLBisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical casesOral Oncol201248875375722401869
   PubMed Web of Science ®Google Scholar
• SchiodtMReibelJOturaiPKofodTComparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification systemOral Surg Oral Med Oral Pathol Oral Radiol2014117220421324332520
   PubMed Web of Science ®Google Scholar
• LazaroviciTSYahalomRTaicherSEladSHardanIYaromNBisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patientsJ Oral Maxillofac Surg200967485085519304045
   PubMed Web of Science ®Google Scholar
• AAOMSAmerican Association of Oral and Maxillofacial Surgeons. Position paper on medication-related osteonecrosis of the jaw2014 [cited July 16, 2014]. Available from: http://www.aaoms.org/members/resources/aaoms-advocacy-and-position-statements/
   Google Scholar
• FedeleSBedogniGScoletteaMUp to a quater of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosedBr J Oral & Maxillofac Surg Epub1012014
   Web of Science ®Google Scholar
• ItzsteinCCoxonFPRogersMJThe regulation of osteoclast function and bone resorption by small GTPasesSmall GTPases20112311713021776413
   PubMedGoogle Scholar
• LaceyDLBoyleWJSimonetWSBench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumabNat Rev Drug Discov201211540141922543469
   PubMed Web of Science ®Google Scholar
• FizaziKCarducciMSmithMDenosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyLancet2011377976881382221353695
   PubMed Web of Science ®Google Scholar
• HenryDHCostaLGoldwasserFRandomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myelomaJ Clin Oncol20112991125113221343556
   PubMed Web of Science ®Google Scholar
• RecknorCCzerwinskiEBoneHGDenosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trialObstet Gynecol201312161291129923812464
   PubMed Web of Science ®Google Scholar
• SchwarzPRasmussenAQKvistTMAndersenUBJorgensenNRPaget’s disease of the bone after treatment with Denosumab: a case reportBone20125051023102522586699
   PubMed Web of Science ®Google Scholar
• RizzoliRBodyJJBrandiMLCancer-associated bone diseaseOsteoporos Int201324122929295324146095
   PubMed Web of Science ®Google Scholar
• KochFPWalterCHansenTJagerEWagnerWOsteonecrosis of the jaw related to sunitinibOral Maxillofac Surg2011151636620401503
   PubMedGoogle Scholar
• FleissigYRegevELehmanHSunitinib related osteonecrosis of jaw: a case reportOral Surg Oral Med Oral Pathol Oral Radiol Endod20121133e1e3
   Web of Science ®Google Scholar
• EstiloCLFornierMFarookiACarlsonDBohleG3rdHurynJMOsteonecrosis of the jaw related to bevacizumabJ Clin Oncol200826244037403818711196
   PubMed Web of Science ®Google Scholar
• GreuterSSchmidFRuhstallerTThuerlimannBBevacizumab-associated osteonecrosis of the jawAnn Oncol200819122091209218977851
   PubMed Web of Science ®Google Scholar
• GuarneriVMilesDRobertNBevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancerBreast Cancer Res Treat2010122118118820361252
   PubMed Web of Science ®Google Scholar
• HoppRNPucciJSantos-SilvaARJorgeJOsteonecrosis after administration of intravitreous bevacizumabJ Oral Maxillofac Surg201270363263521757280
   PubMed Web of Science ®Google Scholar
• KatsenosSChristophylakisCPsathakisKOsteonecrosis of the jaw in a patient with advanced non-small-cell lung cancer receiving bevacizumabArch Bronconeumol201248621821922429334
   PubMed Web of Science ®Google Scholar
• SerraEPaolantonioMSpotoGMastrangeloFTeteSDolciMBevacizumab-related osteneocrosis of the jawInt J Immunopathol Pharmacol20092241121112320074477
   PubMed Web of Science ®Google Scholar
• BettiniGBlandamuraSSaiaGBedogniABevacizumab-related osteonecrosis of the mandible is a self-limiting disease processBMJ Case Rep2012222012
   Google Scholar
• VahtsevanosKKyrgidisAVerrouELongitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jawJ Clin Oncol200927325356536219805682
   PubMed Web of Science ®Google Scholar
• YamashitaJMcCauleyLKAntiresorptives and osteonecrosis of the jawJ Evid Based Dent Pract2012123 Suppl23324723040351
   PubMedGoogle Scholar
• Van den WyngaertTDelforgeMDoyenCProspective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumorsSupport Care Cancer201321123483349023955094
   PubMed Web of Science ®Google Scholar
• BrufskyAMSereikaSMMathewATomifumiOSinghVRosenzweigMLong-term treatment with intravenous bisphosphonates in metastatic breast cancer: a retrospective studyBreast J201319550451123800050
   PubMed Web of Science ®Google Scholar
• OttoSSchreyerCHafnerSBisphosphonate-related osteonecrosis of the jaws – characteristics, risk factors, clinical features, localization and impact on oncological treatmentJ Craniomaxillofac Surg201240430330921676622
   PubMed Web of Science ®Google Scholar
• YamazakiTYamoriMIshizakiTIncreased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort studyInt J Oral Maxillofac Surg201241111397140322840716
   PubMed Web of Science ®Google Scholar
• BeuselinckBWolterPKaradimouAConcomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastasesBr J Cancer2012107101665167123132391
   PubMed Web of Science ®Google Scholar
• RajeNWooSBHandeKClinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jawClin Cancer Res20081482387239518413829
   PubMed Web of Science ®Google Scholar
• SarasqueteMEGarcia-SanzRMarinLBisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysisBlood200811272709271218594024
   PubMed Web of Science ®Google Scholar
• OttoSPautkeCOpelzCOsteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanismJ Oral Maxillofac Surg201068112837284520971371
   PubMed Web of Science ®Google Scholar
• UlmnerMJarnbringFTorringOOsteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonateJ Oral Maxillofac Surg2013721768223992777
   PubMed Web of Science ®Google Scholar
• Statistics Denmark2014 Available from: http://www.dst.dkAccessed September 9, 2014
   Google Scholar
• Statistics Norway2014 Available from: http://www.ssb.noAccessed September 9, 2014
   Google Scholar
• Statistics Sweden2014 Available from: http://www.scb.seAccessed September 9, 2014
   Google Scholar